Challenges in Monitoring Pediatric Cardio-Oncology Patients

Dr. Kasey Leger, Associate Professor of Pediatrics Seattle Children’s & University of Washington She leads the Children’s Oncology Group Myeloid Cardiotoxicity taskforce and the cardiac aims imbedded in the ongoing Phase 3 COG trial evaluating cardioprotective strategies and cardiotoxicity predictors in de novo pediatric AML Dr. Will Border Chief Physician Wellness Officer | Children’s Healthcare of Atlanta Director of Noninvasive Imaging | Children’s Healthcare of Atlanta Cardiology Professor of Pediatrics | Emory University School of Medicine October 26, 2023 Pediatric Cardio-Oncology Virtual Summit, registration and more information here: https://members.ic-os.org/events/register.aspx?id=1778866